In contrast, our work uncovers an intrinsic resistance mechanism in BRCA1/2-sufficient PCa cells, involving two frequently mutated tumor suppressor genes TP53 and CHEK2. The role of p53 and its upstream activator CHK2 in a set of tightly regulated cell cycle checkpoints and DDR events has been extensively studied. Here, CHEK2 is linked to posterior cortical atrophy.